Skip to main content
. 2024 Jul 19;70(7):e20231537. doi: 10.1590/1806-9282.20231537

Table 1. Selected characteristics of the patients with nonalcoholic fatty liver disease and controlsa.

Variables Patients (n=150) Controls (n=154) p-value
Age (years) 38.1 (9.3) 29.0 (7.4) <0.001
Body mass index (kg/m2) 29.4 (5.0) 23.2 (3.3) <0.001
Sex
Men 109 (72.7) 80 (51.9)
Women 41 (27.3) 74 (48.1) <0.001
Smoking history
No 111 (74.0) 140 (90.9)
Former 19 (12.7) 9 (5.8)
Current 20 (13.3) 5 (3.3) 0.020
Systolic blood pressure (mmHg) 123.8 (15.3) 113.9 (13.4) <0.001
Diastolic blood pressure (mmHg) 74.5 (9.8) 70.0 (8.1) <0.001
Aspartate aminotransferase (IU/L) 39.4 (17.1) 19.8 (7.1) <0.001
Alanine aminotransferase (IU/L) 71.1 (39.9) 19.5 (10.2) <0.001
Gamma glutamyl transferase (IU/L) 57.8 (31.4) 19.1 (8.3) <0.001
Steatosis
Grade 0
Grade 1 38 (25.3)
Grade 2 81 (54.0)
Grade 3 31 (20.7)
Necroinflammation
Grade 0 46 (30.7)
Grade 1 57 (38.0)
Grade 2 45 (30.0)
Grade 3 2 (1.3)
Fibrosis
Stage 0 88 (58.7)
Stage 1 55 (36.7)
Stage 2 7 (4.6)
Stage 3
Stage 4
a

Variables presented as mean (SD) or number (%).